Background: Although perineural invasion (PNI) is recognized as an adverse prognostic factor in oral tongue squamous cell carcinoma (SCC), the patterns of failure are poorly defined.
| I NT ROD UCTI ON
The 5-year survival rates of patients with oral tongue squamous cell carcinoma (SCC) have not improved over the last 20 years. 1 Identifying factors that put patients at risk for locoregional and distant failure may affect therapeutic recommendations in an effort to improve survival. The histologic identification of perineural invasion (PNI) is generally considered a poor prognostic indicator and has been associated with an increase in recurrence and a decrease in survival. [2] [3] [4] [5] The 2016 National Comprehensive Cancer Network guidelines recommend adjuvant radiotherapy (RT) when PNI is identified after surgical resection. 6 Furthermore, because patients with PNI were included in the European Organisation for Research and Treatment of Cancer 22931, a prospective randomized study comparing postoperative RT alone versus the addition of chemotherapy in high-risk SCCs of the head and neck 7 that showed a survival advantage for
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This article was published online on 9 March 2018. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected 18 April 2018. patients receiving adjuvant cisplatin concurrent with RT, the National Comprehensive Cancer Network recommends considering adjuvant chemoradiotherapy for patients with adverse risk features, including PNI. Understanding patterns of failure associated with PNI may aid decisions on adjuvant therapy, particularly when PNI is identified in isolation. We sought to evaluate the effects of PNI on patterns of disease failure in a cohort of patients with oral tongue SCC.
One limitation of the current literature is the binary reporting of PNI as being simply present or absent, without any standardized definition or gradation of extent of PNI. We sought to evaluate the effects of PNI on patterns of disease failure in a cohort of patients with oral tongue SCC. Furthermore, we examined whether grading the extent of PNI, including percentage of the circumference of nerve involved by cancer, the caliber of nerve involved, intratumoral versus extratumoral PNI, intraneural versus perineural location of PNI foci, and the number of foci detected per section (foci density) may improve risk stratification and propose a new, standardizing reporting characteristic, PNI foci density.
| M ATE RI ALS AN D ME THO DS
We identified a cohort of 381 patients treated with primary surgery for oral tongue SCC from January 1, 2000, through December 31, 2012, in our departmental database. We performed a retrospective review of medical records to obtain patient, tumor, treatment, and outcome data. Approval from the institutional review board of Memorial Sloan Kettering Cancer Center for this study was obtained.
To be eligible for inclusion, patients were required to have histopathologic slides available for review. Three head and neck pathologists (B.X., N.K., and R.A.G.) reviewed all archived tumor specimens for PNI and all other histologic variables, and were blinded to clinical outcomes. Presence or absence of PNI, defined as invasion in, around, or through peripheral nerve, was assessed for each sample. For samples with PNI, further characterization was performed. The percentage of the nerve circumference involved by cancer, the diameter of the nerve involved (nerve caliber), intratumor versus extratumoral PNI, intraneural versus perineural location of PNI, and foci density were analyzed (see Figure 1) . Foci density was defined as the number of PNI foci observed divided by the number of tumor sections reviewed. Tumor size was defined as the greatest diameter of the invasive tumor based on gross and microscopic examination, and was categorized as 4.0 cm or less or >4.0 cm. Other pathologic variables that were assessed included surgical resection margin, lymph node metastases, histologic grade (well, moderately, or poorly differentiated), depth of invasion (DOI; < 5 mm or 5 mm), 8 and vascular invasion. We assessed associations between variables using the chi-square test or Fisher exact test. The primary endpoints were disease-specific survival (DSS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS), and distant recurrence-free survival (DRFS). The LRFS, RRFS, and DRFS were calculated from the date of surgery to the date of local, regional, or distant recurrence, respectively. All recurrences were proven by biopsy. Survival was reported at the median follow-up. A death was considered a DSS event if the patient had active disease at the time of the last disease assessment. The DSS was calculated from the date of surgery to the date of death or last disease assessment. To determine the optimal cutoff of PNI foci density as related to DSS, maximal chi-square analysis was used.
Cox proportional hazards regression model and KaplanMeier statistics were performed to assess outcomes. The logrank test determined the univariate significance of a variable. Adjusting for pathologic and treatment variables, multivariable Cox proportional hazards regression models were created. Hazard ratios (HRs) and 95% confidence intervals (CIs) were used to report magnitude of difference and the strength of the association. Any P values < .05 were considered significant.
| RES U LTS

| Patient characteristics
The study population consisted of 381 patients diagnosed with oral tongue SCC and T1 to T4 classifications. A majority of the patients (58.3%) were men, and the median age was 57 years (range 18-96 years). The median followup period was 39.8 months (range 0.03-150.1 months). The 5-year DSS, LRFS, RRFS, and DRFS for the entire cohort were 81.5%, 79.7%, 83.5%, and 92.6%, respectively. Overall, there were 96 deaths, with 55 related to disease. Recurrent disease developed in 97 patients, including 58 local recurrences, 53 regional recurrences, and 23 distant recurrences. On pathologic review, we found that PNI was present in 105 cases (28%). Patients with PNI were more likely to also have a higher T classification tumor and lymph node metastasis (P < .001 and P < .001, respectively). In addition, neck dissection and adjuvant radiation were more often part of the treatment plan in patients with PNI (P < .001 and P < .001, respectively). A summary of relevant demographic and clinicopathologic factors are provided in Table 1 . 
| Perineural invasion characteristics
In patients with PNI, the circumference of the nerve involved by the tumor was <100% in 37% of the patients. PNI was identified within the tumor in almost all cases; only 1 case was observed outside the tumor. The tumor was also located around the nerve rather than intraneural in the majority of cases (92%). The caliber of nerve involved was <0.5 mm in 90.4% of cases with only 10 tumors (9.6%) showing PNI involving nerves >0.5 mm. Foci density was defined as the total number of foci of PNI identified, divided by the number of tumor sections reviewed by the pathologist. The average number of tumor sections reviewed per case was 9, median 8 (range 2-28 sections). The average and median number of tumor sections reviewed per centimeter of tumor was 4 (range 1-9 sections). The average number of slides per case was 32 (range 4-86). Using maximal chi-square analysis, the optimal cutoff for foci density association with DSS was determined to be 1.17 (P 5 .014). We, therefore, used 1 as the optimal cutoff to differentiate lesions with high and low foci density. Any patient with greater than 1 focus per section was considered to have a high foci density. Most patients with PNI were found to have low foci density (84%).
| Outcomes
Cases of PNI were found to be associated with worse DSS on univariate analysis (HR 5.63; CI 3.27-9.87; P < .001; Table 2 ). On multivariable analysis, when adjusting for tumor size, adjuvant therapy, and lymph node status, patients with PNI demonstrated a decreased DSS (HR 2.40; CI 1.32-4.37; P 5 .004; Table 2 ). Although PNI was predictive on univariate analysis for local (HR 2.24; CI 1.31-3.85; P 5 .003) and regional recurrence (HR 2.27; CI 1.31-3.95; P 5 .004), it was not predictive on multivariable analysis (Table 3) . PNI was also predictive of distant recurrence on univariate analysis; when PNI was present, patients were 6.39 (CI 2.70-15.10; P 5 .003) times more likely to have a distant recurrence. Too few distant recurrent events precluded multivariable analysis on DRFS. Most PNI characteristics, including the circumference of the nerve involved, the caliber of nerve, intratumoral versus extratumoral PNI, and location of PNI foci (intraneural vs perineural) were not predictive of DSS, LRFS, or RRFS (Table 4 ). In contrast, foci density was predictive of DSS (foci density 1 61.8% vs foci density > 1 37.1%; P 5 .006; Table 4 ). In a subgroup analysis of T1 and T2 tumors (n 5 336), high foci density PNI was predictive of a worse DSS (HR 6.03; CI 1.78-20.49; P 5 .004). In all tumors, on multivariable analysis, patients who had foci density >1 had a significantly poorer DSS compared with patients without PNI (HR 3.49; CI 1.53-7.95; P 5 .007; Table 5 ). The impact of foci density on DSS is illustrated in Figure 2A .
On univariate analysis, foci density was associated with a difference in LRFS, RRFS, and DRFS (Table 6 ). For local recurrence, patients with high foci density had an HR of 4.07 when compared with patients with no PNI. When adjusting for tumor size, foci density, margin status, and postoperative adjuvant therapy, foci density was not an independent predictor of LRFS. For regional recurrence, patients with high foci density had an HR of 4.32 when compared with patients with no PNI. When adjusting for DOI, lymph node status, and postoperative adjuvant therapy, PNI was not an independent predictor of RRFS. When high foci density was present, patients were 19.40 times (CI 6.70-56.14; P < .001) more likely to have a distant recurrence on univariate analyses when compared to having no PNI. The rate of distant recurrence at 5 years stratified by foci density was 39.4% of the patients with a foci density of >1, 12.2% for patients with a foci density of 1 and 4.1% for patients without PNI ( Figure 2B ). Too few distant recurrence events precluded multivariable analysis for DRFS. For T1 and T2 tumors, PNI was not associated with differences in the pattern of failure, including LRFS, RRFS, and DRFS.
| DI S CU S S IO N
Several studies have shown that the presence of PNI is a predictor of poor prognosis in oral cavity SCC. [2] [3] [4] [5] Although these findings support PNI as an adverse risk feature, it remains unclear exactly how PNI should be measured, whether PNI should be quantified rather than reported as a binary outcome, and how the identification of PNI should affect clinical management. In the present study, PNI as quantified by foci density in oral tongue SCC was associated with shorter DSS. Other PNI characteristics (including nerve caliber and intraneural invasion) previously associated with worse outcomes for other cancers, did not predict for increased recurrence or decreased survival in this cohort of oral cancer patients. In this patient cohort, the dominant pattern of failure was distant metastasis, without a significant difference in local or regional recurrence rates. Previously reported patterns of failure with PNI in oral cavity SCC vary across retrospective studies. Chinn et al 3 identified a worse DSS in patients with early oral tongue SCC with PNI, which was associated with significantly worse local regional control. Fagan et al 2 attributed PNIassociated disease-related mortality to local failure without differences in regional or distant recurrences. Increased nodal metastasis and regional recurrence with local control has also been observed in PNI-positive oral tongue SCC. 4, 9 In this current study, consistent with previous reports, PNIpositive tumors were associated with a worse DSS. However, in contrast, these findings were not associated with differences in local or regional control rates on multivariate analysis. Interestingly, the presence of PNI did increase the risk of distant metastasis by 6.4-fold. This pattern was even more striking when foci density was analyzed, with high foci cases being associated with a 19.4-fold higher risk of distant metastasis. Distant events in the high foci PNI cohort occur within the first 12 months, indicating that the adverse prognostic implication of high foci density PNI is biologically realized very rapidly. Rates of distant metastasis in oral cavity cancer range from 2% in early-stage tumors 10 to 21% in high-risk head and neck SCC 11 and confers a significantly worse survival. 12, 13 Consistent with previously published literature, the incidence of distant metastasis across all tumor stages was 16% in this cohort. Median survival in this study population was 7.66 months (range 1.01-49.08). Identifying risk factors for distant metastasis represents a strategy to select patients for whom novel chemotherapy regimens might be used with a goal of improving survival. Cases of PNI have also been identified as risk factors for distant metastatic disease in other solid organ cancers. [14] [15] [16] [17] [18] [19] Specifically, associations between SCC PNI and distant metastases have been reported for esophageal, rectal, and oropharyngeal cancer. 14, 16, 17, 20 As illustrated, the main pattern of failure leading to worse prognosis in patients with PNI varies across studies. One possible explanation may be the variable clinical behavior of numerous oral cavity subsites, and potential varying influences of PNI in these different settings. Consolidating all oral cavity sites together may lead to heterogeneous findings. Another possible contributing factor includes different rates of adjuvant RT applied across these studies, ranging from 0%-48%. 9, 21 In a homogenous group of patients with oral tongue SCC, we show here that the presence of PNI significantly affects DSS without affecting local or regional recurrence independent of receiving adjuvant RT.
Furthermore, variable definitions of PNI may also contribute to varied published results for the prognostic significance of PNI in oral cancer. Liebig et al 22 specified that the presence of tumor cells within any of the 3 nerve sheath layers constitutes PNI. However, others have broadened this to include any tumor cells touching a nerve. 2 In the pathology department at Memorial Sloan Kettering Cancer Center, we use the classic definition of invasion in, around, or through peripheral nerves 23 but do not require a certain circumference around the nerve or that the nerve be outside the bulk of the tumor. Chi et al 24 found that interobserver agreement in assessing PNI status was only "fair" and suggested a "more widely accepted, objective, and reproducible criteria is needed for evaluating PNI in oral cavity." The number of tumor sections examined may also directly impact the frequency of PNI detection. In our department, 2 to 3 sections per centimeter of tumor are sampled. Some studies have identified multifocal PNI as a risk feature of worse DSS and an increase in local failure. 5 However, measuring the number of foci without adjusting for tumor size or the number of slides examined may bias the PNI sampling and affect conclusions. In this current work, we propose the use of foci density to control for the number of sections examined for each specimen. This current work is limited by the number of distant metastatic events in this cohort of patients, making it underpowered to use multivariable analysis to control for potential confounding variables. However, comparing across univariate analysis, we found that patients with a high foci density had a 19-fold increased risk of distant metastasis, as compared to a 4-fold risk of local or regional recurrence. This finding suggests that with an increased sample size, high foci density might be independently associated with distant metastasis. Therefore, PNI may reflect a biological process that reflects a propensity for distant metastatic spread, leading to diminished DSS in high foci tumors. This study is subject to the limitations associated with any retrospective study, including selection bias. These data do not necessarily advocate for adjuvant standard chemotherapy for all patients with a high foci density. The European Organisation for Research and Treatment of Cancer 22931 trial compared the addition of adjuvant chemotherapy to postoperative RT in SCCs of the head and neck with high-risk features, including PNI. Overall survival was not improved with the addition of standard adjuvant chemotherapy and there was no impact on distant metastases. The purpose of this study was to highlight patterns of failure so that more effective adjuvant regimens may be developed to improve survival for patients with oral tongue SCC and PNI. Additionally, recognizing that PNI may represent a distant metastatic phenotype provides clinical rationale to study biologic mechanisms that may be driving this process.
In conclusion, we demonstrate that a novel PNI histologic characteristic reporting system, foci density, has prognostic utility for oral tongue SCC. High foci density is strongly associated with a decrease in DSS on multivariate analyses, and the dominant pattern of failure in this cohort was through distant metastasis. These results support the reporting and study of PNI, using a graded reporting system, in larger cohorts of patients with oral tongue SCC.
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